These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12860592)

  • 21. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergency department guideline concordance with respect to pneumonia antibiotic therapy: we can do better.
    Naughtin SJ
    Emerg Med Australas; 2014 Apr; 26(2):210. PubMed ID: 24708020
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antimicrobial stewardship for the prevention of antimicrobial resistance].
    Aoshima M
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():538-41. PubMed ID: 17455677
    [No Abstract]   [Full Text] [Related]  

  • 24. Fluoroquinolones for respiratory infections: too valuable to overuse.
    Williams JH
    Chest; 2001 Dec; 120(6):1771-5. PubMed ID: 11742900
    [No Abstract]   [Full Text] [Related]  

  • 25. CMS issues much-anticipated EMTALA guidelines.
    Brown LC; Cochran RG
    J Trauma Nurs; 2004; 11(3):107-10. PubMed ID: 16512270
    [No Abstract]   [Full Text] [Related]  

  • 26. Inappropriate fluoroquinolone use resulting from lack of specific guidelines.
    Luh JY; Karnath BM
    Arch Intern Med; 2003 Sep; 163(16):1978. PubMed ID: 12963575
    [No Abstract]   [Full Text] [Related]  

  • 27. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.
    Bolon MK; Wright SB; Gold HS; Carmeli Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1934-40. PubMed ID: 15155181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.
    Moran G
    J Emerg Med; 2006 May; 30(4):377-87. PubMed ID: 16740445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guideline compliance improves pneumonia care.
    ED Manag; 2006 Feb; 18(2):17-8. PubMed ID: 16499273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experience.
    Arnold FW; Patel A; Nakamatsu R; Smith RS; Newman D; Sciortino CV; Peyrani P; Snyder J; Schulz P; Ramirez JA
    J Ky Med Assoc; 2007 Sep; 105(9):431-7. PubMed ID: 17941421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of fluoroquinolone resistance among Bacteroides species.
    Golan Y; McDermott LA; Jacobus NV; Goldstein EJ; Finegold S; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Rihs J; Iannini P; Gorbach SL; Snydman DR
    J Antimicrob Chemother; 2003 Aug; 52(2):208-13. PubMed ID: 12865399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Family practice-friendly guidelines. Anti-infective guidelines (1994-2005).
    Dunn L; Jordan J; Martino F; Meuser J; Pilla J; Stewart J; Rosser WW
    Can Fam Physician; 2006 Jan; 52():71-2. PubMed ID: 16477911
    [No Abstract]   [Full Text] [Related]  

  • 33. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
    Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobials: an endangered species?
    Gould IM
    Int J Antimicrob Agents; 2007 Nov; 30(5):383-4. PubMed ID: 17825532
    [No Abstract]   [Full Text] [Related]  

  • 35. Community-acquired pneumonia guidelines: Peering back through the looking glass...clearly?
    Peterson MW; Hornick DB
    Am J Med; 2004 Nov; 117(10):799-800. PubMed ID: 15541330
    [No Abstract]   [Full Text] [Related]  

  • 36. Utilization of parenteral anti-infective agents in the medical emergency unit of a tertiary care hospital: an observational study.
    Gupta M; Malhotra S; Chandra KK; Sharma N; Pandhi P
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):653-7. PubMed ID: 15362089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emergency department crowding paradox: the longer you stay, the less care you get.
    Hollander JE; Pines JM
    Ann Emerg Med; 2007 Nov; 50(5):497-9. PubMed ID: 17583380
    [No Abstract]   [Full Text] [Related]  

  • 38. The Emergency Medical Treatment and Active Labor Act (EMTALA): guidelines for compliance.
    Peth HA
    Emerg Med Clin North Am; 2004 Feb; 22(1):225-40. PubMed ID: 15062507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring antibiotic timing for pneumonia in the emergency department: another nail in the coffin.
    Pines JM
    Ann Emerg Med; 2007 May; 49(5):561-3. PubMed ID: 17350732
    [No Abstract]   [Full Text] [Related]  

  • 40. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
    Garin N; Nendaz M
    Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.